734501687	734501687	CD	B-NP	O
|	|	NN	I-NP	O
SH	SH	NN	I-NP	O
|	|	NN	I-NP	O
77229115	77229115	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8931164	8931164	CD	B-NP	O
|	|	CC	I-NP	O
5/20/2007	5/20/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
HEPATIC	HEPATIC	NNP	I-NP	I-protein
ENCEPHALOPATHY	ENCEPHALOPATHY	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/8/2007	4/8/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/22/2007	7/22/2007	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
DAFT	DAFT	NNP	B-NP	O
,	,	,	O	O
PABLO	PABLO	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
GI	GI	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Chirico	Chirico	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
50-year-old	50-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
Hep-C	Hep-C	NN	B-NP	B-protein
and	and	CC	I-NP	O
NASH	NASH	NN	I-NP	O
cirrhosis	cirrhosis	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
presumed	presume	VBN	B-NP	O
hepatic	hepatic	JJ	I-NP	O
encephalopathy	encephalopathy	NN	I-NP	O
after	after	IN	B-PP	O
being	be	VBG	B-VP	O
found	find	VBN	I-VP	O
unresponsive	unresponsive	JJ	B-ADJP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
apartment	apartment	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
on	on	IN	B-PP	O
3/17/2007	3/17/2007	CD	B-NP	O
for	for	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
distention	distention	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	B-NP	O
labs	lab	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
no	no	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
,	,	,	O	O
LFTs	LFT	NNS	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
ammonia	ammonia	NN	B-NP	O
of	of	IN	B-PP	O
81	81	CD	B-NP	O
.	.	.	O	O

Plan	Plan	NN	B-NP	O
was	be	VBD	B-VP	O
for	for	IN	B-PP	O
paracentesis	paracentesis	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
refused	refuse	VBD	B-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
left	leave	VBD	B-VP	O
AMA	AMA	NN	B-NP	O
before	before	IN	B-SBAR	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
GI	GI	NN	I-NP	O
doctor	doctor	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
arranged	arrange	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
family	family	NN	I-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
contact	contact	VB	I-VP	O
him	him	PRP	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
on	on	IN	B-PP	O
6/11/2007	6/11/2007	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
friend	friend	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
checked	check	VBD	B-VP	O
him	him	PRP	B-NP	O
out	out	RP	B-PRT	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
morning	morning	NN	I-NP	O
on	on	IN	B-PP	O
1/13/2006	1/13/2006	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
alone	alone	RB	B-ADJP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
apartment	apartment	NN	I-NP	O
and	and	CC	I-NP	O
unresponsive	unresponsive	JJ	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Charl	Charl	NNP	I-NP	O
Lubspi	Lubspi	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
by	by	IN	B-PP	O
EMS	EMS	NNP	B-NP	O
on	on	IN	B-PP	O
10/28/2007	10/28/2007	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
tachycardic	tachycardic	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
febrile	febrile	JJ	I-ADJP	O
to	to	TO	B-PP	O
100.2	100.2	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
only	only	RB	B-ADJP	O
able	able	JJ	I-ADJP	O
to	to	TO	B-VP	O
open	open	VB	I-VP	O
eyes	eye	NNS	B-NP	O
to	to	TO	B-PP	O
commands	command	NNS	B-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADJP	O
noncommunicative	noncommunicative	JJ	I-ADJP	O
per	per	IN	B-PP	O
report	report	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
and	and	CC	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
paracentesis	paracentesis	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
liters	liter	NNS	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
peritonitis	peritonitis	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
dropped	drop	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
80	80	CD	I-NP	O
's	's	POS	B-NP	O
post-paracentesis	post-paracentesis	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
with	with	IN	B-PP	O
troponin	troponin	NN	B-NP	O
of	of	IN	B-PP	O
0.49	0.49	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
course	course	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
UTI	UTI	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
rising	rise	VBG	B-VP	O
from	from	IN	B-PP	O
0.8	0.8	CD	B-NP	O
and	and	CC	I-NP	O
1.5	1.5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
extensive	extensive	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cardiac/GI	cardiac/GI	NN	B-NP	O
treatment	treatment	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Systems/leaj	Systems/leaj	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Nonwelle	Nonwelle	NNP	I-NP	O
Geshall	Geshall	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Of	Of	NNP	I-NP	O
on	on	IN	B-PP	O
4/8/2007	4/8/2007	CD	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Nonalcoholic	Nonalcoholic	JJ	B-NP	O
steatohepatitis	steatohepatitis	NN	I-NP	O
:	:	:	O	O
Undergoing	Undergo	VBG	B-VP	O
liver	liver	NN	B-NP	O
transplant	transplant	NN	I-NP	O
workup	workup	NN	I-NP	O
.	.	.	O	O

HAV	HAV	NN	B-NP	O
,	,	,	I-NP	O
HCV	HCV	NN	I-NP	O
reactive	reactive	JJ	I-NP	O
.	.	.	O	O

HBV	HBV	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Smooth	Smooth	JJ	B-NP	B-protein
muscle	muscle	NN	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

Large	Large	JJ	B-NP	O
volume	volume	NN	I-NP	O
ascites	ascite	NNS	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
paracenteses	paracentes	NNS	I-NP	O
from	from	IN	B-PP	O
3/29	3/29	CD	B-NP	O
through	through	IN	B-PP	O
8/13	8/13	CD	B-NP	O
.	.	.	O	O

Liver	Liver	NN	B-NP	O
biopsied	biopsie	VBD	B-VP	O
on	on	IN	B-PP	O
8/12	8/12	CD	B-NP	O
with	with	IN	B-PP	O
portal	portal	JJ	B-NP	O
mononuclear	mononuclear	JJ	I-NP	O
inflammation	inflammation	NN	I-NP	O
,	,	,	O	O
micro/macrovesicular	micro/macrovesicular	JJ	B-NP	O
steatosis	steatosis	NN	I-NP	O
,	,	,	O	O
focal	focal	JJ	B-NP	O
sinusoidal	sinusoidal	JJ	I-NP	O
fibrosis	fibrosis	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CAD	CAD	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
stent	stent	NN	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
done	do	VBN	B-VP	O
3/16/2006	3/16/2006	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
proximal	proximal	JJ	B-NP	O
LAD	LAD	NN	I-NP	O
with	with	IN	B-PP	O
ostial	ostial	JJ	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
?	?	.	O	O
?	?	.	O	O
____	____	''	O	B-protein
?	?	.	O	I-protein
?	?	.	O	I-protein
LIMA	LIMA	NNP	B-NP	I-protein
touchdown	touchdown	VBD	B-VP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
ostial	ostial	JJ	I-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
,	,	,	O	O
totally	totally	RB	B-ADVP	O
occluded	occlude	VBD	B-VP	O
RCA	RCA	NN	B-NP	B-protein
,	,	,	O	O
patent	patent	NN	B-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
and	and	CC	I-NP	O
patent	patent	NN	I-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
PDA	PDA	NN	B-NP	B-protein
and	and	CC	I-NP	O
radial	radial	NN	I-NP	O
to	to	TO	B-PP	O
diagonal	diagonal	JJ	B-NP	O
,	,	,	O	O
but	but	CC	O	O
radial	radial	JJ	B-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
OM	OM	NN	B-NP	O
was	be	VBD	B-VP	O
totally	totally	RB	I-VP	O
occluded	occlude	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
bare-metal	bare-metal	JJ	I-NP	O
stent	stent	NN	I-NP	O
placed	place	VBN	B-VP	O
to	to	TO	I-VP	O
left	left	VB	I-VP	O
circumflex	circumflex	NN	B-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
CABG	CABG	NNP	B-NP	O
in	in	IN	B-PP	O
4/17	4/17	CD	B-NP	O
with	with	IN	B-PP	O
LIMA	LIMA	NN	B-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
PDA	PDA	NN	B-NP	B-protein
,	,	,	O	O
renal	renal	JJ	B-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
OM	OM	NN	B-NP	O
and	and	CC	O	O
diagonal	diagonal	JJ	B-ADJP	O
.	.	.	O	O

Asymptomatic	Asymptomatic	JJ	B-ADJP	O
since	since	IN	B-PP	O
CABG	CABG	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
in	in	IN	B-PP	O
workup	workup	NN	B-NP	O
for	for	IN	B-PP	O
liver	liver	NN	B-NP	O
transplant	transplant	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
troponin	troponin	NN	B-NP	O
and	and	CC	O	O
taken	take	VBN	B-VP	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
,	,	,	O	O
mild	mild	JJ	B-ADJP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Asthma	Asthma	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Morbid	Morbid	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Thrombocytopenia	Thrombocytopenia	NNP	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
large	large	JJ	B-NP	O
volume	volume	NN	I-NP	O
taps	tap	NNS	I-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Albuterol	Albuterol	NN	B-NP	O
two	two	CD	B-NP	O
puff	puff	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
500/50	500/50	CD	I-NP	O
inhaler	inhaler	IN	B-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
from	from	IN	B-PP	O
40	40	CD	B-NP	O
,	,	,	O	O
prior	prior	RB	B-ADVP	O
from	from	IN	B-PP	O
80	80	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	B-protein
month	month	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
metformin	metformin	NN	B-NP	O
850	850	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Avandia	Avandia	NNP	B-NP	O
8	8	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
lactulose	lactulose	VB	B-VP	O
30	30	CD	B-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	VBP	B-VP	O
TRANSFER	TRANSFER	NN	B-NP	O
FROM	FROM	NN	I-NP	O
GSVH	GSVH	NN	I-NP	O
:	:	:	O	O
Albuterol	Albuterol	NN	B-NP	O
90	90	CD	B-NP	O
mcg	mcg	NN	I-NP	O
two	two	CD	B-NP	O
puff	puff	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
,	,	,	O	O
fluticasone/salmeterol	fluticasone/salmeterol	NN	B-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
rifaximin	rifaximin	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
nadolol	nadolol	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
lactulose	lactulose	VB	B-VP	O
30	30	CD	B-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
atorvastatin	atorvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
pantoprazole	pantoprazole	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
:	:	:	O	O
Urticaria	Urticaria	NNP	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Metoprolol	Metoprolol	NN	B-NP	O
:	:	:	O	O
Bronchospasm	Bronchospasm	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
AND	AND	CC	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
96.5	96.5	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
54-63	54-63	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
106/54	106/54	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
SAO2	SAO2	NN	B-NP	B-protein
of	of	IN	B-PP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
An	An	DT	B-NP	O
obese-appearing	obese-appearing	JJ	I-NP	O
male	male	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Normocephalic	Normocephalic	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
atraumatic	atraumatic	JJ	I-ADJP	O
,	,	,	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
scleral	scleral	JJ	I-NP	O
icterus	icterus	NN	I-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
equals	equal	VBZ	B-VP	O
8	8	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	I-NP	O
wheezes	wheeze	NNS	I-NP	O
or	or	CC	I-NP	O
rhonchi	rhonchi	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Distant	Distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Very	Very	NN	B-NP	O
protuberant	protuberant	NN	I-NP	O
and	and	CC	O	O
distended	distend	VBN	B-VP	O
,	,	,	O	O
bruising	bruise	VBG	B-VP	O
throughout	throughout	IN	B-ADVP	O
,	,	,	O	O
fluid	fluid	NN	B-NP	O
wave	wave	VBP	B-VP	O
present	present	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
normal	normal	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
four	four	CD	I-NP	O
quadrants	quadrant	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
HSM	HSM	NN	I-NP	B-protein
or	or	CC	I-NP	O
masses	mass	NNS	I-NP	O
palpated	palpate	VBN	B-VP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
or	or	CC	I-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	O	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
knees	knee	NNS	I-NP	O
,	,	,	O	O
anasarca	anasarca	NN	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
radial	radial	NN	I-NP	O
pulses	pulse	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Derm	Derm	NN	B-NP	O
:	:	:	O	O
Prominent	Prominent	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
wall	wall	NN	I-NP	O
varices	varix	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
common	common	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
caput	caput	NN	I-NP	O
,	,	,	O	O
prominent	prominent	JJ	B-NP	O
bruising	bruising	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
palmar	palmar	JJ	I-NP	O
erythema	erythema	NN	I-NP	O
or	or	CC	I-NP	O
spider	spider	NN	I-NP	O
angiomas	angioma	NNS	I-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
to	to	TO	B-PP	O
person	person	NN	B-NP	O
,	,	,	I-NP	O
place	place	NN	I-NP	O
and	and	CC	I-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
II	II	CD	B-NP	O
through	through	IN	B-PP	O
XII	XII	NN	B-NP	B-DNA
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Motor	Motor	NN	B-NP	O
strength	strength	NN	I-NP	O
and	and	CC	I-NP	O
sensation	sensation	NN	I-NP	O
are	be	VBP	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
asterixis	asterixis	NN	I-NP	O
.	.	.	O	O

NOTABLE	NOTABLE	NNP	B-NP	O
STUDIES	STUDIES	NNPS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
Diagnostic/therapeutic	Diagnostic/therapeutic	JJ	B-NP	O
paracenteses	paracentes	NNS	I-NP	O
x4	x4	NN	I-NP	O
using	use	VBG	B-VP	O
abdominal	abdominal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
to	to	TO	B-VP	O
mark	mark	VB	I-VP	O
site	site	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
volumes	volume	NNS	I-NP	O
removed	remove	VBD	B-VP	O
:	:	:	O	O
6	6	CD	B-NP	O
liters	liter	NNS	I-NP	O
,	,	,	O	O
6	6	CD	B-NP	O
liters	liter	NNS	I-NP	O
,	,	,	O	O
1.2	1.2	CD	B-NP	O
liters	liter	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
6	6	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Hepatic	Hepatic	JJ	B-NP	O
encephalopathy	encephalopathy	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Davern	Davern	NNP	I-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
oriented	oriented	JJ	I-ADJP	O
,	,	,	O	O
but	but	CC	O	O
still	still	RB	B-ADJP	O
very	very	RB	I-ADJP	O
confused	confused	JJ	I-ADJP	O
with	with	IN	B-PP	O
limited	limited	JJ	B-NP	O
verbal	verbal	JJ	I-NP	O
communication	communication	NN	I-NP	O
.	.	.	O	O

Baseline	Baseline	NN	B-NP	O
ammonia	ammonia	NN	I-NP	O
on	on	IN	B-PP	O
1/26/2007	1/26/2007	CD	B-NP	O
was	be	VBD	B-VP	O
66	66	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
lactulose	lactulose	NN	B-NP	O
and	and	CC	I-NP	O
rifaximin	rifaximin	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
to	to	TO	B-PP	O
3-4	3-4	CD	B-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noncompliant	noncompliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
lactulose	lactulose	NN	B-NP	O
regimen	regimen	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
confusion	confusion	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
responsiveness	responsiveness	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
these	these	DT	B-NP	O
episodes	episode	NNS	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
or	or	CC	I-NP	O
ABG	ABG	NN	I-NP	O
changes	change	NNS	I-NP	O
suspicious	suspicious	JJ	B-ADJP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
or	or	CC	I-NP	O
hypercapnia	hypercapnia	NN	I-NP	O
or	or	CC	I-NP	O
hypoxia	hypoxia	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
his	his	PRP$	B-NP	O
agitation	agitation	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
restraints	restraint	NNS	B-NP	O
after	after	IN	B-PP	O
which	which	WDT	B-NP	O
his	his	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
improved	improve	VBD	B-VP	O
,	,	,	O	O
inflicting	inflict	VBG	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
voluntary	voluntary	JJ	I-NP	O
and	and	CC	I-NP	O
metabolic	metabolic	JJ	I-NP	O
component	component	NN	I-NP	O
is	be	VBZ	B-VP	O
decompensation	decompensation	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-PP	O
contract	contract	NN	B-NP	O
with	with	IN	B-PP	O
healthcare	healthcare	NN	B-NP	O
team	team	NN	I-NP	O
as	as	IN	B-PP	O
his	his	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
improved	improve	VBD	B-VP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
compliant	compliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
oriented	oriented	JJ	I-ADJP	O
,	,	,	O	O
appropriately	appropriately	RB	B-ADJP	O
interactive	interactive	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
ammonia	ammonia	NN	I-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
.	.	.	O	O

Plans	Plan	NNS	B-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Chhuon	Chhuon	NNP	I-NP	O
for	for	IN	B-PP	O
continued	continued	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
possible	possible	JJ	I-NP	O
liver	liver	NN	I-NP	O
transplant	transplant	NN	I-NP	O
and	and	CC	I-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hepatic	hepatic	JJ	I-NP	O
encephalopathy	encephalopathy	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
lactulose	lactulose	NN	I-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	I-NP	O
rifaximin	rifaximin	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Ascites	Ascite	NNS	B-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Angeles	Angeles	NNP	I-NP	O
's	's	POS	B-NP	O
intake	intake	NN	I-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
225	225	CD	B-NP	O
pounds	pound	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	B-protein
underwent	undergo	VBD	B-VP	I-protein
diagnostic	diagnostic	JJ	B-NP	I-protein
therapeutic	therapeutic	JJ	I-NP	I-protein
paracenteses	paracentes	NNS	I-NP	I-protein
x4	x4	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
first	first	JJ	I-NP	O
two	two	CD	I-NP	O
and	and	CC	I-NP	O
fourth	fourth	JJ	I-NP	O
procedures	procedure	NNS	I-NP	O
removed	remove	VBD	B-VP	O
6	6	CD	B-NP	O
liters	liter	NNS	I-NP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
removed	remove	VBD	B-VP	O
1.2	1.2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

Before	Before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
each	each	DT	B-NP	O
tap	tap	NN	I-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
infused	infuse	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
albumin	albumin	NN	I-NP	O
at	at	IN	B-PP	O
8	8	CD	B-NP	O
g/liter	g/liter	NN	I-NP	O
of	of	IN	B-PP	O
ascites	ascite	NNS	B-NP	O
fluid	fluid	NN	I-NP	O
removed	remove	VBN	B-VP	O
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
ascites	ascite	NNS	B-NP	O
fluid	fluid	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
SAAG	SAAG	NN	I-NP	B-protein
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
,	,	,	I-NP	O
2.7	2.7	CD	I-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
2.8	2.8	CD	B-NP	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
portal	portal	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ascites	ascite	NNS	I-NP	O
fluid	fluid	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
peritonitis	peritonitis	NN	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
each	each	DT	B-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Records	Records	NNP	I-NP	O
remained	remain	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
80-90/40	80-90/40	CD	B-NP	O
-50	-50	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	I-NP	O
weights	weight	NNS	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-NP	O
following	follow	VBG	I-NP	O
paracentesis	paracentesis	NN	I-NP	O
,	,	,	O	O
reflecting	reflect	VBG	B-VP	O
limited	limited	JJ	B-NP	O
reaccumulation	reaccumulation	NN	I-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

Discharge	Discharge	NN	B-NP	O
weight	weight	NN	I-NP	O
is	be	VBZ	B-VP	O
299.9	299.9	CD	B-NP	O
pounds	pound	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
diuretics	diuretic	NNS	B-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
his	his	PRP$	B-NP	O
ascites	ascite	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
reasonable	reasonable	JJ	I-NP	O
level	level	NN	I-NP	O
including	include	VBG	B-PP	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	O	O
Aldactone	Aldactone	NN	B-NP	B-protein
200	200	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
:	:	:	O	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	I-NP	O
Aldactone	Aldactone	NN	I-NP	O
were	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Mr.	Mr.	NNP	B-NP	O
Selim	Selim	NNP	I-NP	O
's	's	POS	B-NP	O
stay	stay	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
KVGH	KVGH	NN	I-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
after	after	IN	B-PP	O
increasing	increase	VBG	B-VP	O
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
0.8	0.8	CD	B-NP	O
to	to	TO	B-PP	O
1.4	1.4	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
transfer	transfer	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
hypotension	hypotension	NN	B-NP	O
with	with	IN	B-PP	O
consequent	consequent	JJ	B-NP	O
renal	renal	JJ	I-NP	O
hypoperfusion	hypoperfusion	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Dayhoff	Dayhoff	NNP	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
empiric	empiric	JJ	B-NP	O
hydration	hydration	NN	I-NP	O
challenge	challenge	NN	I-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
normal	normal	JJ	I-NP	O
saline	saline	NN	I-NP	O
and	and	CC	I-NP	O
albumin	albumin	NN	I-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
proved	prove	VBD	B-VP	O
responsive	responsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
dropping	drop	VBG	B-VP	O
from	from	IN	B-PP	O
1.4	1.4	CD	B-NP	O
to	to	TO	B-PP	O
1.1	1.1	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
and	and	CC	O	O
Aldactone	Aldactone	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
gradually	gradually	RB	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
discharge	discharge	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	I-NP	O
Aldactone	Aldactone	NN	I-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
0.7	0.7	CD	B-NP	O
to	to	TO	B-PP	O
0.9	0.9	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Averbeck	Averbeck	NNP	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hypotension	Hypotension	NN	B-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Boger	Boger	NNP	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
following	follow	VBG	B-PP	O
paracentesis	paracentesis	NN	B-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
and	and	CC	I-NP	O
nifedipine	nifedipine	NN	I-NP	O
were	be	VBD	B-VP	O
consequently	consequently	RB	I-VP	O
held	hold	VBN	I-VP	O
and	and	CC	I-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
his	his	PRP$	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-PP	O
90	90	CD	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
nadolol	nadolol	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
transfer	transfer	NN	B-NP	O
.	.	.	O	O

Throughout	Throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
current	current	JJ	I-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Veroeven	Veroeven	NNP	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
have	have	VBP	B-VP	O
remained	remain	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
80-90/40	80-90/40	CD	I-NP	O
-50	-50	CD	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Troponin	Troponin	NN	B-NP	O
leak	leak	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Swogger	Swogger	NNP	I-NP	O
's	's	POS	B-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
hypovolemic	hypovolemic	JJ	B-NP	O
hypoperfusion	hypoperfusion	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Zocor	Zocor	NNP	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
stents	stent	NNS	I-NP	O
and	and	CC	O	O
CABG	CABG	NN	B-NP	B-protein
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
from	from	IN	B-PP	O
0.49	0.49	CD	B-NP	O
to	to	TO	B-PP	O
0.15	0.15	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Zocor	Zocor	NNP	B-NP	O
,	,	,	O	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
asymptomatic	asymptomatic	JJ	I-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
troponin	troponin	NN	I-NP	O
performed	perform	VBN	B-VP	O
on	on	IN	B-PP	O
1/26/2007	1/26/2007	CD	B-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
0.1	0.1	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

UTI	UTI	LS	B-LST	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Couvertier	Couvertier	NNP	I-NP	O
had	have	VBD	B-VP	O
positive	positive	JJ	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
3-day	3-day	JJ	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Cipro	Cipro	NNP	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
performed	perform	VBN	B-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Guaiac-positive	Guaiac-positive	JJ	B-NP	O
stool	stool	NN	I-NP	O
:	:	:	O	O
Likely	Likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
straining	strain	VBG	B-VP	O
,	,	,	O	O
esophageal	esophageal	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
anorectal	anorectal	JJ	B-NP	O
varices	varix	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
35	35	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
43	43	CD	B-NP	I-DNA
.	.	.	O	O

At	At	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
recommended	recommend	VBD	B-VP	O
workup	workup	NN	B-NP	O
in	in	IN	B-PP	O
EGD	EGD	NN	B-NP	B-protein
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Graniela	Graniela	NNP	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Contact	Contact	JJ	B-NP	O
dermatitis	dermatitis	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
9	9	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
contact	contact	NN	I-NP	O
dermatitis	dermatitis	NN	I-NP	O
on	on	IN	B-PP	O
inner	inner	JJ	B-NP	O
aspect	aspect	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
thighs	thigh	NNS	I-NP	O
,	,	,	O	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
urinary	urinary	JJ	I-NP	O
and	and	CC	I-NP	O
fecal	fecal	JJ	I-NP	O
incontinence	incontinence	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
topical	topical	JJ	B-NP	O
hydrocortisone	hydrocortisone	NN	I-NP	O
and	and	CC	I-NP	O
miconazole	miconazole	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
an	an	DT	B-NP	O
infected	infected	JJ	I-NP	O
skin	skin	NN	I-NP	O
tag	tag	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
back	back	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
topical	topical	JJ	B-NP	O
bacitracin	bacitracin	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
treated	treat	VBN	I-VP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
and	and	CC	O	O
followed	follow	VBD	B-VP	O
up	up	RP	B-PRT	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
:	:	:	O	O
Throughout	Throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Lynne	Lynne	NNP	I-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
fingerstick	fingerstick	NN	B-NP	O
showing	show	VBG	B-VP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
to	to	TO	B-PP	O
190	190	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
metformin	metformin	NN	I-NP	O
and	and	CC	O	O
Avandia	Avandia	NNP	B-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
required	require	VBD	B-VP	O
minimal	minimal	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
rehab	rehab	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
p.o.	p.o.	FW	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Avandia	Avandia	NNP	B-NP	O
and	and	CC	O	O
metformin	metformin	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Orizetti	Orizetti	NNP	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
1.7	1.7	CD	B-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
decreased	decrease	VBN	B-NP	O
synthetic	synthetic	JJ	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
liver	liver	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
3-day	3-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
K	K	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Code	Code	NN	B-NP	O
status	status	NN	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Disposition	Disposition	NN	B-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
rehab	rehab	VB	I-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
inhaler	inhaler	NN	I-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
bacitracin	bacitracin	NN	B-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
applied	apply	VBN	B-VP	O
to	to	TO	B-VP	O
affected	affect	VBN	I-VP	O
area	area	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
Diskus	Diskus	NNP	I-NP	O
250/50	250/50	CD	I-NP	O
two	two	CD	I-NP	O
puffs	puff	NNS	I-NP	O
inhaler	inhal	JJR	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
5000	5000	CD	I-NP	O
units	unit	NNS	I-NP	O
subq	subq	NN	I-NP	O
q.	q.	NN	I-NP	O
8	8	CD	I-NP	O
h.	h.	NN	I-NP	O
,	,	,	O	O
hydrocortisone	hydrocortisone	NN	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
cream	cream	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
applied	apply	VBN	B-VP	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
areas	area	NNS	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
aspart	aspart	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
lactulose	lactulose	RB	B-NP	O
45	45	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
nitrate	nitrate	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	B-ADJP	O
,	,	,	O	O
applied	apply	VBN	B-VP	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
areas	area	NNS	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
rifaximin	rifaximin	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
Aldactone	Aldactone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
multivitamin	multivitamin	NN	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
to	to	TO	B-VP	O
work	work	VB	I-VP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
appointments	appointment	NNS	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Janda	Janda	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Woolhouse	Woolhouse	NNP	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
notify	notify	VB	I-VP	O
your	your	PRP$	B-NP	O
doctors	doctor	NNS	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
become	become	VBP	B-VP	O
increasingly	increasingly	RB	B-ADJP	O
confused	confuse	VBN	I-ADJP	O
,	,	,	O	O
experiencing	experience	VBG	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
lose	lose	NN	B-NP	O
consciousness	consciousness	NN	I-NP	O
,	,	,	O	O
rapid	rapid	JJ	B-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Belson	Belson	NNP	I-NP	O
,	,	,	O	O
GI	GI	NNP	B-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
follow-up	follow-up	JJ	B-NP	O
appointment	appointment	NN	I-NP	O
,	,	,	O	O
please	please	VB	B-INTJ	O
assess	assess	VB	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
for	for	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
ascites	ascite	NNS	B-NP	O
,	,	,	O	O
medication	medication	NN	B-NP	O
compliance	compliance	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
titrate	titrate	NN	B-NP	O
diuretics	diuretic	NNS	I-NP	O
and	and	CC	O	O
lactulose	lactulose	NN	B-NP	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
outpatient	outpatient	NN	B-NP	O
EGD	EGD	NN	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
your	your	PRP$	B-NP	O
esophageal	esophageal	JJ	I-NP	O
varices	varix	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Stoehr	Stoehr	NNP	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
follow-up	follow-up	JJ	B-NP	O
appointment	appointment	NN	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
assess	assess	NN	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
contact	contact	NN	I-NP	O
dermatitis	dermatitis	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
infected	infected	JJ	B-NP	O
skin	skin	NN	I-NP	O
tag	tag	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
back	back	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Rehab	Rehab	NN	B-NP	O
:	:	:	O	O
Physical	Physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
to	to	TO	B-VP	O
work	work	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

Ensure	Ensure	NN	B-NP	O
medication	medication	NN	I-NP	O
compliance	compliance	NN	I-NP	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
transition	transition	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
diabetic	diabetic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Avandia	Avandia	NNP	B-NP	O
8	8	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	I-NP	O
metformin	metformin	NN	I-NP	O
850	850	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Cockman	Cockman	NNP	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Newsted	Newsted	NNP	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
9-6738259	9-6738259	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
SABISTON	SABISTON	NNP	B-NP	O
,	,	,	O	O
CHI	CHI	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
YAGI	YAGI	NNP	B-NP	O
,	,	,	O	O
EARNEST	EARNEST	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8483062	8483062	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
6/25/07	6/25/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/25/07	6/25/07	CD	B-NP	O

